Impaired TFEB Activation and Mitophagy as a Cause of PPP3/Calcineurin Inhibitor-Induced Pancreatic β-Cell Dysfunction

Scientists studied whether PPP3/calcineurin inhibitors could affect the mitophagy of pancreatic β-cells and pancreatic β-cell function by employing FK506, an immunosuppressive drug against graft rejection.